The role of nitric oxide on visual-evoked potentials in MPTP-induced Parkinsonism in mice

Neurochemistry International

Volumn 72, Issue 1, 2014, Pages 48-57

  Aras, Sinem ^a   Tanriover, Gamze ^a   Aslan, Mutay ^a   Yargicoglu, Piraye ^a   Agar, Aysel ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

iNOS; MPTP; nNOS; Parkinson; VEPs

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 HYDROXYNONENAL; 7 NITRA INDAZOLE; CASPASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; S METHYLPSEUDOTHIOUREA; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; 4-HYDROXY-2-NONENAL; ALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EVOKED VISUAL RESPONSE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MEASUREMENT; MOTOR ACTIVITY; MOTOR COORDINATION; MOUSE; MPTP-INDUCED PARKINSONISM; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RETINA; SUBSTANTIA NIGRA; ANIMAL; C57BL MOUSE; DRUG EFFECTS; INTOXICATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE;

ALDEHYDES; ANIMALS; CASPASE 3; EVOKED POTENTIALS, VISUAL; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MPTP POISONING; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PSYCHOMOTOR PERFORMANCE; TYROSINE 3-MONOOXYGENASE;

EID: 84900462545     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.04.014     Document Type: Article

References (56)

1. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10 Suppl 2004 S18 S25
2. M.T. Baltazar, R.J. Dinis-Oliveira, M. de Lourdes Bastos, A.M. Tsatsakis, J.A. Duarte, and F. Carvalho Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases-a mechanistic approach Toxicol. Lett. 2014 10.1016/j.toxlet.2014.01.039 (pii: S0378-4274(14)00059-9)
3. V.A. Baraboi The role of lipid peroxidation in the mechanism of stress Fiziol. Zh. 35 5 1989 85 97
4. G. Bazzu, G. Calia, G. Puggioni, Y. Spissu, G. Rocchitta, and P. Debetto et al. Alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach CNS Neurol. Disord. Drug Targets. 9 4 2010 482 490
5. R. Betarbet, T.B. Sherer, and J.T. Greenamyre Animal models of Parkinson's disease BioEssays 24 4 2002 308 318 (Pubitemid 34305686)
6. I. Bodis-Wollner, and M.D. Yahr Measurements of visual evoked potentials in Parkinson's disease Brain 101 4 1978 661 671 (Pubitemid 9051163)
7. Y.C. Boo, S.L. Tressel, and H. Jo An improved method to measure nitrate/nitrite with an NO-selective electrochemical sensor Nitric Oxide 16 2 2007 306 312 (PMCID: 1850282) (Pubitemid 46149386)
8. G.C. Brown Nitric oxide and neuronal death Nitric Oxide 23 3 2010 153 165
9. M.J. Brzozowski, S.L. Alcantara, M.M. Iravani, S. Rose, and P. Jenner The effect of nNOS inhibitors on toxin-induced cell death in dopaminergic cell lines depends on the extent of enzyme expression Brain Res. 1404 2011 21 30
10. O. Bugnon, N.C. Schaad, and M. Schorderet Nitric oxide modulates endogenous dopamine release in bovine retina Neuroreport 5 4 1994 401 404 (Pubitemid 24128625)
11. T. Buttner, W. Kuhn, T. Muller, T. Heinze, C. Puhl, and H. Przuntek Chromatic and achromatic visual evoked potentials in Parkinson's disease Electroencephalogr. Clin. Neurophysiol. 100 5 1996 443 447
12. K.P. Castagnoli, S.J. Steyn, J.P. Petzer, C.J. Van der Schyf, and N. Castagnoli Jr. Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco Chem. Res. Toxicol. 14 5 2001 523 527 (Pubitemid 32480020)
13. G.G. Celesia Evoked potential techniques in the evaluation of visual function J. Clin. Neurophysiol. 1 1 1984 55 76 (Pubitemid 14104588)
14. I. Date, D.L. Felten, and S.Y. Felten Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis Brain Res. 519 1-2 1990 266 276 (Pubitemid 20199698)
15. V. Di Matteo, M. Pierucci, A. Benigno, G. Crescimanno, E. Esposito, and G. Di Giovanni Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study Ann. N. Y. Acad. Sci. 1155 2009 309 315
16. M.B. Djamgoz, J.R. Cunningham, S.L. Davenport, and M.J. Neal Nitric oxide inhibits depolarization-induced release of endogenous dopamine in the rabbit retina Neurosci. Lett. 198 1 1995 33 36
17. Y. Du, Z. Ma, S. Lin, R.C. Dodel, F. Gao, and K.R. Bales et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Proc. Natl. Acad. Sci. U.S.A. 98 25 2001 14669 14674 (PMCID: 64739) (Pubitemid 33121449)
18. O. Eberhardt, and J.B. Schulz Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease Toxicol. Lett. 139 2-3 2003 135 151 (Pubitemid 36298972)
19. S. Guo, J. Yan, T. Yang, X. Yang, E. Bezard, and B. Zhao Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway Biol. Psychiatry 62 12 2007 1353 1362 (Pubitemid 350180727)
20. J.M. Gutteridge Biological origin of free radicals, and mechanisms of antioxidant protection Chem. Biol. Interact. 91 2-3 1994 133 140 (Pubitemid 24168459)
21. N. Hattoria, M. Wanga, H. Taka, T. Fujimura, A. Yoritaka, and S. Kubo et al. Toxic effects of dopamine metabolism in Parkinson's disease Parkinsonism Relat. Disord. 15 Suppl 1 2009 S35-8
22. C. Hesslinger, A. Strub, R. Boer, W.R. Ulrich, M.D. Lehner, and C. Braun Inhibition of inducible nitric oxide synthase in respiratory diseases Biochem. Soc. Trans. 37 Pt 4 2009 886 891
23. M.M. Iravani, K. Kashefi, P. Mander, S. Rose, and P. Jenner Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration Neuroscience 110 1 2002 49 58 (Pubitemid 34214759)
24. P. Jenner Oxidative mechanisms in nigral cell death in Parkinson's disease Mov. Disord. 13 Suppl 1 1998 24 34
25. C. Ji, V. Amarnath, J.A. Pietenpol, and L.J. Marnett 4-Hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release Chem. Res. Toxicol. 14 8 2001 1090 1096 (Pubitemid 32800165)
26. A.S. Kalgutkar, and N. Castagnoli Jr. Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors J. Med. Chem. 35 22 1992 4165 4174
27. A. Kastner, M.T. Herrero, E.C. Hirsch, J. Guillen, M.R. Luquin, and F. Javoy-Agid et al. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy Ann. Neurol. 36 2 1994 206 214 (Pubitemid 24239238)
28. P.M. Kidd Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management Altern. Med. Rev. 5 6 2000 502 529 (Pubitemid 32104062)
29. J. Kishimoto, T. Tsuchiya, P.C. Emson, and Y. Nakayama Immobilization-induced stress activates neuronal nitric oxide synthase (nNOS) mRNA and protein in hypothalamic-pituitary-adrenal axis in rats Brain Res. 720 1-2 1996 159 171 (Pubitemid 26179823)
30. T.L. Krukoff Central actions of nitric oxide in regulation of autonomic functions Brain Res. Brain Res. Rev. 30 1 1999 52 65 (Pubitemid 29331515)
31. V. Kucukatay, G. Hacioglu, F. Savcioglu, P. Yargicoglu, and A. Agar Visual evoked potentials in normal and sulfite oxidase deficient rats exposed to ingested sulfite Neurotoxicology 27 1 2006 93 100 (Pubitemid 41745012)
32. T. Langheinrich, L. Tebartz van Elst, W.A. Lagreze, M. Bach, C.H. Lucking, and M.W. Greenlee Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics Clin. Neurophysiol. 111 1 2000 66 74
33. C. Levecque, A. Elbaz, J. Clavel, F. Richard, J.S. Vidal, and P. Amouyel et al. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study Hum. Mol. Genet. 12 1 2003 79 86 (Pubitemid 36104179)
34. M.G. Lima, C. Maximino, K.R. Matos Oliveira, A. Brasil, M.E. Crespo-Lopez, J. Batista Ede, F.A. Rocha, D.L. Picanço-Diniz, and A.M. Herculano Nitric oxide as a regulatory molecule in the processing of the visual stimulus Nitric Oxide 36 2014 44 50
35. M.J. Neal, J.R. Cunningham, and K.L. Matthews Release of endogenous ascorbic acid preserves extracellular dopamine in the mammalian retina Invest. Ophthalmol. Vis. Sci. 40 12 1999 2983 2987 (Pubitemid 29521614)
36. S. Nightingale, K.W. Mitchell, and J.W. Howe Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects J. Neurol. Neurosurg. Psychiatry 49 11 1986 1280 1287 (PMCID: 1029077) (Pubitemid 17174030)
37. V.B. O'Donnell, P.H. Chumley, N. Hogg, A. Bloodsworth, V.M. Darley-Usmar, and B.A. Freeman Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol Biochemistry 36 49 1997 15216 15223 (Pubitemid 27527986)
38. N. Ogawa Dopamine neurotransmission and treatments for Parkinson's disease in the molecular biology era Eur. Neurol. 38 Suppl 1 1997 2 5 (Pubitemid 27326691)
39. B. Okuda, H. Tachibana, K. Kawabata, M. Takeda, and M. Sugita Visual evoked potentials (VEPs) in Parkinson's disease: correlation of pattern VEPs abnormality with dementia Alzheimer Dis. Assoc. Disord. 9 2 1995 68 72
40. D. O'Mahony, M. Rowan, J. Feely, D. O'Neill, J.B. Walsh, and D. Coakley Parkinson's dementia and Alzheimer's dementia: an evoked potential comparison Gerontology 39 4 1993 228 240 (Pubitemid 23264133)
41. O. Ozsoy, G. Tanriover, N. Derin, N. Uysal, N. Demir, and B. Gemici et al. The effect of docosahexaenoic acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B Neurotox. Res. 20 3 2011 250 262
42. H.S. Pall, A.C. Williams, D.R. Blake, P. Winyard, and J. Lunec Lipid peroxidation and Parkinson's disease Lancet 2 8511 1986 870 871 (Pubitemid 17178075)
43. J.J. Pang, F. Gao, and S.M. Wu Light responses and morphology of bNOS-immunoreactive neurons in the mouse retina J. Comp. Neurol. 518 13 2010 2456 2474 (PMCID: 3000797)
44. N.S. Peachey, and S.L. Ball Electrophysiological analysis of visual function in mutant mice Doc. Ophthalmol. 107 1 2003 13 36 (Pubitemid 36896235)
45. S. Przedborski, V. Jackson-Lewis, R. Yokoyama, T. Shibata, V.L. Dawson, and T.M. Dawson Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity Proc. Natl. Acad. Sci. U.S.A. 93 10 1996 4565 4571 (PMCID: 39317)
46. Z. Qi, G.W. Miller, and E.O. Voit Rotenone and paraquat perturb dopamine metabolism: a computational analysis of pesticide toxicity Toxicology 315 2014 92 101
47. H.O. Sener, M.C. Akbostanci, C. Yucesan, B. Dora, and D. Selcuki Visual evoked potentials in Parkinson's disease-correlation with clinical involvement Clin. Neurol. Neurosurg. 103 3 2001 147 150 (Pubitemid 32816277)
48. M. Smeyne, and R.J. Smeyne Method for culturing postnatal substantia nigra as an in vitro model of experimental Parkinson's disease Brain Res. Brain Res. Protoc. 9 2 2002 105 111 (Pubitemid 34595442)
49. L. Soulere, Y. Queneau, and A. Doutheau An expeditious synthesis of 4-hydroxy-2E-nonenal (4-HNE), its dimethyl acetal and of related compounds Chem. Phys. Lipids 150 2 2007 239 243 (Pubitemid 47554550)
50. G.M. Strain, and B.L. Tedford Flash and pattern reversal visual evoked potentials in C57BL/6J and B6CBAF1/J mice Brain Res. Bull. 32 1 1993 57 63 (Pubitemid 23160581)
51. K. Tieu, H. Ischiropoulos, and S. Przedborski Nitric oxide and reactive oxygen species in Parkinson's disease IUBMB Life 55 6 2003 329 335 (Pubitemid 36975543)
52. M.H. Tran, K. Yamada, A. Olariu, M. Mizuno, X.H. Ren, and T. Nabeshima Amyloid beta-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors FASEB J. 15 8 2001 1407 1409
53. A.H. Vielma, M.A. Retamal, and O. Schmachtenberg Nitric oxide signaling in the retina: what have we learned in two decades? Brain Res. 1430 2012 112 125
54. T. Wichmann, and M.R. DeLong Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder Ann. N. Y. Acad. Sci. 991 2003 199 213 (Pubitemid 36793815)
55. H. Yokoyama, H. Kuroiwa, J. Kasahara, and T. Araki Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson's disease Acta Neurobiol. Exp. (Wars) 71 2 2011 269 280
56. L. Zhou, and D.Y. Zhu Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications Nitric Oxide 20 4 2009 223 230